
Opinion|Videos|July 16, 2024
Managing Evaporative Dry Eye with New FDA-Approved Therapy
Experts provide clinical insights on the first FDA-approved treatment for evaporative dry eye, perfluorohexyloctane ophthalmic solution (MEIBO).
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- We now have the first FDA-approved treatment for evaporative dry eye [perfluorohexyloctane ophthalmic solution (MIEBO)]. What is significant about this new treatment?
- Why do we need to target evaporative dry eye specifically?
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Early SPECTRUM results outline week 8 real-world outcomes with aflibercept 8 mg
2
Contact Lens Institute rings in 2026 Visionaries
3
Higher head elevation during sleep may be associated with higher IOP, study suggests
4
Alcon's PRECISION7 sphere, toric contact lenses now available in Canada
5





























